3
Announcements
Trials
Browse
Landscape
Status
Completed
5
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Tumor-Agnostic
1
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Dermatologic
1
Breast
1
Conditions
Non-small Cell Lung Cancer Metastatic
1
Interventions
Carboplatin
131
pembrolizumab
112
Pemetrexed
91
Cisplatin
86
durvalumab
64
Paclitaxel
58
osimertinib
55
Nivolumab
55
Docetaxel
44
atezolizumab
41
Etoposide
30
Radiotherapy
28
Radiosurgery
26
Gemcitabine
26
Specimen Handling
24
Ipilimumab
23
Taxes
19
Magnetic Resonance Spectroscopy
19
amivantamab
16
Drug Therapy
15
Bevacizumab
15
130-nm albumin-bound paclitaxel
15
Radiation
14
Platinum
14
Immunoglobulin G
14
Disulfides
14
cemiplimab
13
Crizotinib
13
lazertinib
11
Cyclophosphamide
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Data Collection
×
Thoracic
×
Clear all
NCT04994795
2024-11-21
DEEP-Lung-IV
Sophia Genetics SAS
Active not recruiting
4,000 enrolled